Nasal stem cell spray could slow Alzheimer's – first human test begins
NCT ID NCT07554872
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests whether a nasal spray containing particles from neural stem cells is safe for people with moderate-to-severe early-onset Alzheimer's. Nine participants aged 50-75 will receive different dosing schedules over 28 days. The main goal is to check for side effects, but researchers will also look for signs of cognitive improvement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE (AD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, 200030, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple beat help Alzheimer's patients walk better?
- Lifestyle makeover could slash Alzheimer's risk in genetically vulnerable seniors
- New study offers hope for lonely Alzheimer's caregivers
- New cognitive test aims to catch Alzheimer's earlier with help from memory nurses
- Can silkworm powder boost brain health in Alzheimer's?
- New imaging study aims to spot immune cells in Alzheimer's brains